Market Insights Snapshot
Even Cannabis Company concentrated 88.97% of June 2026 sales in Edible, with Flower at 5.92% and Topical at 5.11%, while overall brand sales were down 82.82% year over year and average price fell 7.37%. Within that mix, Edible declined 83.45% year over year but rose 8.72% month over month, Topical fell 83.19% year over year and 14.48% month over month, and Flower lacked a year-over-year baseline but dropped 72.81% month over month, placing the brand at rank 27 in Edible in Ontario. The pattern implies an over-reliance on Edible where a modest monthly uptick is not offsetting deep annual contraction, and the sharp month-over-month retreat in Flower alongside a double-digit month-over-month decline in Topical suggests portfolio fragility concentrated in a single category.
With 88.97% share anchored in Edible and a category rank of 27 in Ontario, the 8.72% month-over-month lift likely reflects near-term promotional or pricing tactics rather than durable demand given the 83.45% year-over-year drop and a 7.37% brand-wide price decrease. The 72.81% month-over-month contraction in Flower and the 14.48% month-over-month decline in Topical indicate reduced breadth just as Edible volatility persists, implying the brand’s positioning skews toward a single-price, single-format play that limits cross-category resilience and leaves share exposed if Edible momentum stalls.
Competitive Landscape
Even Cannabis Company sits at rank #27 in ON Edible in June 2026, down 3 positions year over year from #24, while improving 3 spots since March 2026 when it was #30; the brand’s peak was #24 in August 2025, indicating a 3-rank slide from that high and a flat year-over-year peak comparison at #24. In the same June 2026 period, Spinach held #1 with a 9.9% year-over-year sales lift and Wyld rose from #4 to #3 with 21.9% growth, whereas Even Cannabis Company moved from #24 to #27 without a corresponding rank gain; additionally, Olli advanced from #7 to #4 alongside 120.7% growth, contrasting with Even Cannabis Company’s 3-position year-over-year decline and 3-position quarter-over-quarter rise. The pattern implies Even Cannabis Company is stabilizing off its March 2026 trough but ceding relative share to faster-advancing leaders, so absent an acceleration that converts the recent 3-rank quarterly recovery into a year-over-year climb, mid-pack drift is likely.

Notable Products
Biggies Cherry Cola Live Resin Soft Chews 4-Pack (10mg) posted the largest month-over-month surge at +152.6% to reach rank 2, while Gary Satan (3.5g) plunged -72.8% to rank 4; this divergence implies demand is consolidating in Edibles while Flower loses momentum. CBD Mango Lemonade Gummies 30-Pack (750mg CBD) in rank 1 grew +9.6% and, together with two other Edibles in the top six, concentrates three of the top six in one category; the category skew suggests Even Cannabis Company is leaning into gummy-led velocity rather than a balanced portfolio.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







